PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Does the body's immune response to viral vector delivery systems affect the safety or efficacy of gene therapy?

2014-01-08
(Press-News.org) Contact information: Vicki Cohn
vcohn@liebertpub.com
914-740-2100 x2156
Mary Ann Liebert, Inc./Genetic Engineering News
Does the body's immune response to viral vector delivery systems affect the safety or efficacy of gene therapy?

New Rochelle, NY, January 7, 2014—Packaging replacement genes in viruses is an effective method to deliver them to target tissues, but the human body mounts an immune response against the virus. The systemic and local immune reactions induced by an adeno-associated virus (AAV)-based gene therapy to treat lipoprotein lipase deficiency, approved for use in Europe, does not affect the safety of gene therapy or expression of the replacement gene for at least one year after delivery, according to a study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Human Gene Therapy website.

Valeria Ferreira and coauthors, uniQure BV and Academic Medical Center, Amsterdam, the Netherlands, and University of Montreal and Chicoutimi Hospital, Quebec, Canada, evaluated measures of inflammation and adverse clinical events and the expression of a replacement lipoprotein lipase (LPL) gene that was injected intramuscularly into patients with LPL deficiency. The gene was packaged in an AAV vector, as described in the article "Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPLS447X) in a phase II clinical trial of Lipoprotein Lipase deficiency (LPLD) gene therapy."

"The clinical data published in this paper were critical to the approval of Glybera," says James Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy and Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia. "Furthermore, they provide context for laboratory measurements of immune responses which apparently did not impact product performance."



INFORMATION:

About the Journal

Human Gene Therapy, the official journal of the European Society of Gene and Cell Therapy, British Society for Gene and Cell Therapy, French Society of Cell and Gene Therapy, German Society of Gene Therapy, and five other gene therapy societies, is an authoritative peer-reviewed journal published monthly in print and online. Human Gene Therapy presents reports on the transfer and expression of genes in mammals, including humans. Related topics include improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, as well as ethical, legal, and regulatory issues related to the gene transfer in humans. Its sister journals are Human Gene Therapy Methods, published bimonthly and focused on the application of gene therapy to product testing and development, and Human Gene Therapy Clinical Development, published quarterly and featuring data relevant to the regulatory review and commercial development of cell and gene therapy products. Tables of content for all three publications and a sample issue may be viewed on the Human Gene Therapy website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Nucleic Acid Therapeutics, Tissue Engineering, Stem Cells and Development, and Cellular Reprogramming. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
http://www.liebertpub.com
Phone: (914) 740-2100
(800) M-LIEBERT
Fax: (914) 740-2101



ELSE PRESS RELEASES FROM THIS DATE:

Research reveals new therapeutic target for Huntington's disease

2014-01-08
Research reveals new therapeutic target for Huntington's disease

Geography has impact on grapevine moth's success in French vineyards

2014-01-08
Geography has impact on grapevine moth's success in French vineyards Study sheds light on how regional differences, local temperatures influence immune function of pests 'Location, location, location' is an adage also true for the European grapevine moth, it seems. Research ...

Laundering money -- literally -- could save billions of dollars

2014-01-08
Laundering money -- literally -- could save billions of dollars A dollar bill gets around, passing from hand to hand, falling on streets and sidewalks, eventually getting so grimy that a bank machine flags it and sends it to the shredder. Rather than destroying ...

Newly discovered celestial object defies categories

2014-01-08
Newly discovered celestial object defies categories Scientists asking if it is a new kind of planet or a rare kind of failed star TORONTO, ON – An object discovered by astrophysicists at the University of Toronto (U of T) nearly 500 light years away from the Sun ...

Metal ink could ease the way toward flexible electronic books, displays

2014-01-08
Metal ink could ease the way toward flexible electronic books, displays Scientists are reporting the development of a novel metal ink made of small sheets of copper that can be used to write a functioning, flexible electric circuit on regular printer paper. ...

Green space can make people happier for years

2014-01-08
Green space can make people happier for years Nearly 10 years after the term "nature deficit disorder" entered the nation's vocabulary, research is showing for the first time that green space does appear to improve mental health in a sustained way. The report, ...

Top chemical advances and more from the year 2013

2014-01-08
Top chemical advances and more from the year 2013 From stretchy electronics to Martian chemistry, the most notable advances in the chemical world in 2013 appear in the year-in-review issue of Chemical & Engineering News (C&EN), the weekly newsmagazine of the ...

AML score that combines genetic and epigenetic changes might help guide therapy

2014-01-08
AML score that combines genetic and epigenetic changes might help guide therapy COLUMBUS, Ohio – Currently, doctors use chromosome markers and gene mutations to determine the best treatment for patients with acute myeloid leukemia (AML). ...

Cosmetic outcomes after breast-conserving therapy may vary by race

2014-01-08
Cosmetic outcomes after breast-conserving therapy may vary by race Subjective ratings appear lower in African-American patients, reports PRS Global Open Philadelphia, Pa. (January 7, 2013) – As perceived by both patients and doctors, the cosmetic results ...

Stopping tumors in their path

2014-01-08
Stopping tumors in their path New study sheds light on most common and deadly form of brain cancer Glioblastoma (GBM) is the most common and deadly form of primary malignant brain cancer accounting for approximately 15% of all brain tumours and occurring mostly in adults between ...

LAST 30 PRESS RELEASES:

Older teens who start vaping post-high school risk rapid progress to frequent use

Corpse flowers are threatened by spotty recordkeeping

Riding the AI wave toward rapid, precise ocean simulations

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

[Press-News.org] Does the body's immune response to viral vector delivery systems affect the safety or efficacy of gene therapy?